Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SMBS
Schwab Mortgage-Backed Securities ETF
SMBS
|
+$5.08B |
| 2 |
Schwab Municipal Bond ETF
SCMB
|
+$1.29B |
| 3 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$752M |
| 4 |
Microsoft
MSFT
|
+$699M |
| 5 |
NVIDIA
NVDA
|
+$578M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$4.9B |
| 2 |
Invesco FTSE RAFI US 1000 ETF
PRF
|
+$986M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$951M |
| 4 |
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
|
+$794M |
| 5 |
Schwab Fundamental International Small Company Index ETF
FNDC
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.55% |
| 2 | Financials | 11.83% |
| 3 | Healthcare | 9.33% |
| 4 | Consumer Discretionary | 9.25% |
| 5 | Industrials | 8.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SVCO
3326
Silvaco Group
SVCO
$245M
| $287K | ﹤0.01% |
60,832
+108
| +0.2% | +$511 |
|
3327
Lifezone Metals
LZM
$372M
| $287K | ﹤0.01% |
69,596
-16,733
| -19% | -$62.3K |
|
3328
Finward Bancorp
FNWD
$193M
| $287K | ﹤0.01% |
+10,381
| New | +$307K |
|
3329
Westwood Holdings Group
WHG
$188M
| $286K | ﹤0.01% |
+18,344
| New | +$286K |
|
3330
Nuvectis Pharma
NVCT
$623M
| $284K | ﹤0.01% |
+37,982
| New | +$344K |
|
3331
Empire Petroleum
EP
$109M
| $283K | ﹤0.01% |
53,631
| – | – |
|
3332
Arena Group
AREN
$76.2M
| $282K | ﹤0.01% |
+45,556
| New | +$224K |
|
|
TVRD
3333
Tvardi Therapeutics
TVRD
$22.5M
| $281K | ﹤0.01% |
+12,052
| New | +$285K |
|
3334
CVRx
CVRX
$65.3M
| $278K | ﹤0.01% |
47,293
+5,388
| +13% | +$37.2K |
|
3335
SunPower Inc
SPWR
$49.6M
| $277K | ﹤0.01% |
+150,675
| New | +$260K |
|
3336
Consumer Portfolio Services
CPSS
$202M
| $276K | ﹤0.01% |
28,096
+3,169
| +13% | +$29.1K |
|
3337
TriSalus Life Sciences
TLSI
$356M
| $273K | ﹤0.01% |
50,012
+40,012
| +400% | +$215K |
|
3338
Nkarta
NKTX
$167M
| $269K | ﹤0.01% |
161,776
+14,225
| +10% | +$26.1K |
|
3339
Mobile Infrastructure Corp
BEEP
$108M
| $266K | ﹤0.01% |
58,651
+36,151
| +161% | +$146K |
|
|
ARAI
3340
Arrive AI Inc
ARAI
$14.6M
| $264K | ﹤0.01% |
+22,625
| New | +$179K |
|
3341
Sanara MedTech
SMTI
$314M
| $262K | ﹤0.01% |
9,221
-2,135
| -19% | -$64K |
|
3342
GrowGeneration
GRWG
$87.7M
| $261K | ﹤0.01% |
279,598
-175,135
| -39% | -$187K |
|
3343
American Vanguard Corp
AVD
$64.4M
| $261K | ﹤0.01% |
66,629
+6
| +0% | +$25 |
|
3344
Waldencast
WALD
$174M
| $260K | ﹤0.01% |
106,148
+41,253
| +64% | +$104K |
|
3345
Protalix BioTherapeutics
PLX
$197M
| $259K | ﹤0.01% |
+175,070
| New | +$358K |
|
3346
Cartesian Therapeutics
RNAC
$260M
| $259K | ﹤0.01% |
24,903
-4,400
| -15% | -$46.9K |
|
3347
Lexeo Therapeutics
LXEO
$374M
| $258K | ﹤0.01% |
64,220
+8,046
| +14% | +$26.5K |
|
|
TEAD
3348
Teads Holding Co
TEAD
$65M
| $258K | ﹤0.01% |
103,996
-286
| -0.3% | -$865 |
|
3349
Bakkt Inc
BKKT
$332M
| $255K | ﹤0.01% |
+18,296
| New | +$202K |
|
3350
Travelzoo
TZOO
$73.9M
| $255K | ﹤0.01% |
+20,030
| New | +$263K |
|
Similar funds
Charles Schwab's Q2 2025 Portfolio in Review
As of Q2 2025, Charles Schwab held 3,631 positions worth $578B, up 8.5% from $533B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Charles Schwab's Q2 2025 filing shows 158 new, 2,252 increased, 1,020 reduced and 137 closed positions. Its largest new stake was Schwab Mortgage-Backed Securities ETF: 202,020,489 shares worth $5.15B. The largest sale was Vanguard Mortgage-Backed Securities ETF, an estimated $4.9B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2025 buy was Schwab Mortgage-Backed Securities ETF: 202,020,489 shares worth $5.15B.
- Charles Schwab added most to Schwab Municipal Bond ETF in Q2 2025, an estimated $1.29B increase.
- Charles Schwab's biggest Q2 2025 reduction was Vanguard Mortgage-Backed Securities ETF, cutting an estimated $4.9B.
- Charles Schwab fully exited Invesco FTSE RAFI US 1000 ETF in Q2 2025, selling an estimated $986M.
- Charles Schwab's ten largest holdings make up 23% of its $578B portfolio in Q2 2025.
- Charles Schwab opened 158 new positions and closed 137 in Q2 2025.
- Charles Schwab's portfolio value rose 8.5% quarter-over-quarter to $578B.
Based on Charles Schwab's 13F filing for Q2 2025, filed 12 Aug 2025.